Patent · US Active

Composition intended to vectorise an anti-cancer agent

US10716861B2 · kind B2 · utility

0Cited by
3References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 4, 2016
Grant dateJul 21, 2020
Priority date—
Expiry dateAug 18, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K49/101
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A composition in the form of a water-in-oil emulsion comprising: in which:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.